Skip to main content
Top
Published in: International Urogynecology Journal 5/2016

01-05-2016 | Original Article

Incontinence medication response relates to the female urinary microbiota

Authors: Krystal J. Thomas-White, Evann E. Hilt, Cynthia Fok, Meghan M. Pearce, Elizabeth R. Mueller, Stephanie Kliethermes, Kristin Jacobs, Michael J. Zilliox, Cynthia Brincat, Travis K. Price, Gina Kuffel, Paul Schreckenberger, Xiaowu Gai, Linda Brubaker, Alan J. Wolfe

Published in: International Urogynecology Journal | Issue 5/2016

Login to get access

Abstract

Introduction and hypothesis

Many adult women have resident urinary bacteria (urinary microbiome/microbiota). In adult women affected by urinary urgency incontinence (UUI), the etiologic and/or therapeutic role of the urinary microbiome/microbiota remains unknown. We hypothesized that microbiome/microbiota characteristics would relate to clinically relevant treatment response to UUI medication per os.

Methods

Adult women initiating medication treatment orally for UUI and a comparator group of unaffected women were recruited in a tertiary care health-care system. All participants provided baseline clinical data and urine samples. Women with UUI were given 5 mg solifenacin, with potential dose escalation to 10 mg for inadequate UUI symptom control at 4 weeks. Additional data and urine samples were collected from women with UUI at 4 and 12 weeks. The samples were assessed using 16S ribosomal RNA (rRNA) gene sequencing and enhanced quantitative urine culturing. The primary outcome was treatment response as measured by the validated Patient Global Symptom Control (PGSC) questionnaire. Clinically relevant UUI symptom control was defined as a 4 or 5 score on the PGSC.

Results

Diversity and composition of the urinary microbiome/microbiota of women with and without UUI differed at baseline. Women with UUI had more bacteria and a more diverse microbiome/microbiota. The clinical response to solifenacin in UUI participants was related to baseline microbiome/microbiota, with responders more likely to have fewer bacteria and a less diverse community at baseline. Nonresponders had a more diverse community that often included bacteria not typically found in responders.

Conclusions

Knowledge of an individual’s urinary microbiome/microbiota may help refine UUI treatment. Complementary tools, DNA sequencing, and expanded urine culture provide information about bacteria that appear to be related to UUI incontinence status and treatment response in this population of adult women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hartmann KE, McPheeters ML, Biller DH, Ward RM, McKoy JN, Jerome RN, Micucci SR, Meints L, Fisher JA, Scott TA, Slaughter JC, Blume JD (2009) Treatment of overactive bladder in women. Evid Rep/Technol Assess 187:1–120 Hartmann KE, McPheeters ML, Biller DH, Ward RM, McKoy JN, Jerome RN, Micucci SR, Meints L, Fisher JA, Scott TA, Slaughter JC, Blume JD (2009) Treatment of overactive bladder in women. Evid Rep/Technol Assess 187:1–120
2.
go back to reference Hoffstetter S, Leong FC (2009) Solifenacin succinate for the treatment of overactive bladder. Expert Opin Drug Metab Toxicol 5(3):345–350CrossRefPubMed Hoffstetter S, Leong FC (2009) Solifenacin succinate for the treatment of overactive bladder. Expert Opin Drug Metab Toxicol 5(3):345–350CrossRefPubMed
3.
go back to reference Haab F, Cardozo L, Chapple C, Ridder AM, Solifenacin Study Group (2005) Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome. Eur Urol 47(3):376–384CrossRefPubMed Haab F, Cardozo L, Chapple C, Ridder AM, Solifenacin Study Group (2005) Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome. Eur Urol 47(3):376–384CrossRefPubMed
4.
go back to reference Pelman RS, Capo JP Jr, Forero-Schwanhaeuser S (2008) Solifenacin at 3 years: a review of efficacy and safety. Postgrad Med 120(2):85–91CrossRefPubMed Pelman RS, Capo JP Jr, Forero-Schwanhaeuser S (2008) Solifenacin at 3 years: a review of efficacy and safety. Postgrad Med 120(2):85–91CrossRefPubMed
5.
go back to reference Santos JC, Telo ER (2010) Solifenacin: scientific evidence in the treatment of overactive bladder. Arch Esp Urol 63(3):197–213PubMed Santos JC, Telo ER (2010) Solifenacin: scientific evidence in the treatment of overactive bladder. Arch Esp Urol 63(3):197–213PubMed
6.
go back to reference Whiteside SA, Razvi H, Dave S, Reid G, Burton JP (2015) The microbiome of the urinary tract - a role beyond infection. Nat Rev Urol 12(2):81–90CrossRefPubMed Whiteside SA, Razvi H, Dave S, Reid G, Burton JP (2015) The microbiome of the urinary tract - a role beyond infection. Nat Rev Urol 12(2):81–90CrossRefPubMed
8.
go back to reference Wolfe AJ, Brubaker L (2015) “Sterile Urine” and the Presence of Bacteria. Eur Urol 68(2):173–174CrossRefPubMed Wolfe AJ, Brubaker L (2015) “Sterile Urine” and the Presence of Bacteria. Eur Urol 68(2):173–174CrossRefPubMed
9.
go back to reference Brubaker L, Nager CW, Richter HE, Visco A, Nygaard I, Barber MD, Schaffer J, Meikle S, Wallace D, Shibata N, Wolfe AJ (2014) Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J 25(9):1179–84CrossRefPubMedPubMedCentral Brubaker L, Nager CW, Richter HE, Visco A, Nygaard I, Barber MD, Schaffer J, Meikle S, Wallace D, Shibata N, Wolfe AJ (2014) Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J 25(9):1179–84CrossRefPubMedPubMedCentral
10.
go back to reference Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, Brubaker L, Gai X, Wolfe AJ, Schreckenberger PC (2014) Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 52(3):871–876CrossRefPubMedPubMedCentral Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, Brubaker L, Gai X, Wolfe AJ, Schreckenberger PC (2014) Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 52(3):871–876CrossRefPubMedPubMedCentral
11.
go back to reference Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, Kliethermes S, Schreckenberger P, Brubaker L, Gai X, Wolfe AJ (2014) The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5(4):e01283–14CrossRefPubMedPubMedCentral Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, Kliethermes S, Schreckenberger P, Brubaker L, Gai X, Wolfe AJ (2014) The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5(4):e01283–14CrossRefPubMedPubMedCentral
12.
go back to reference Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L (2012) Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 50(4):1376–1383CrossRefPubMedPubMedCentral Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L (2012) Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 50(4):1376–1383CrossRefPubMedPubMedCentral
13.
go back to reference Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, Torralba M, Nelson KE, Groah SL (2012) Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 10:174CrossRefPubMedPubMedCentral Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, Torralba M, Nelson KE, Groah SL (2012) Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 10:174CrossRefPubMedPubMedCentral
14.
go back to reference Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS (2011) Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 11:244CrossRefPubMedPubMedCentral Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS (2011) Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 11:244CrossRefPubMedPubMedCentral
15.
go back to reference Khasriya R, Sathiananthamoorthy S, Ismail S, Kelsey M, Wilson M, Rohn JL, Malone-Lee J (2013) Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J Clin Microbiol 51(7):2054–2062CrossRefPubMedPubMedCentral Khasriya R, Sathiananthamoorthy S, Ismail S, Kelsey M, Wilson M, Rohn JL, Malone-Lee J (2013) Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J Clin Microbiol 51(7):2054–2062CrossRefPubMedPubMedCentral
16.
go back to reference Lewis DA, Brown R, Williams J, White P, Jacobson SK, Marchesi JR, Drake MJ (2013) The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infec Microbiol 3:41CrossRef Lewis DA, Brown R, Williams J, White P, Jacobson SK, Marchesi JR, Drake MJ (2013) The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infec Microbiol 3:41CrossRef
17.
go back to reference Barber MD, Walters MD, Cundiff GW (2006) Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse. Am J Obstet Gynecol 194(5):1492–1498CrossRefPubMed Barber MD, Walters MD, Cundiff GW (2006) Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse. Am J Obstet Gynecol 194(5):1492–1498CrossRefPubMed
18.
go back to reference Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 14(2):131–139CrossRefPubMed Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 14(2):131–139CrossRefPubMed
19.
go back to reference Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res : Int J Qual Life Asp Treat, Care Rehabil 11(6):563–574CrossRef Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res : Int J Qual Life Asp Treat, Care Rehabil 11(6):563–574CrossRef
20.
go back to reference Brubaker L, Richter HE, Visco A, Mahajan S, Nygaard I, Braun TM, Barber MD, Menefee S, Schaffer J, Weber AM, Wei J, Pelvic Floor Disorders N (2008) Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180(1):217–222CrossRefPubMedPubMedCentral Brubaker L, Richter HE, Visco A, Mahajan S, Nygaard I, Braun TM, Barber MD, Menefee S, Schaffer J, Weber AM, Wei J, Pelvic Floor Disorders N (2008) Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180(1):217–222CrossRefPubMedPubMedCentral
21.
go back to reference Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75(23):7537–7541CrossRefPubMedPubMedCentral Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75(23):7537–7541CrossRefPubMedPubMedCentral
22.
go back to reference Team RDC (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing Team RDC (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing
23.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed
24.
go back to reference Hooton TM, Roberts PL, Cox ME, Stapleton AE (2013) Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369(20):1883–1891CrossRefPubMedPubMedCentral Hooton TM, Roberts PL, Cox ME, Stapleton AE (2013) Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369(20):1883–1891CrossRefPubMedPubMedCentral
25.
go back to reference Maskell RM (2010) The natural history of urinary tract infection in women. Med Hypotheses 74(5):802–806CrossRefPubMed Maskell RM (2010) The natural history of urinary tract infection in women. Med Hypotheses 74(5):802–806CrossRefPubMed
26.
go back to reference Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK (1982) Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 307(8):463–468CrossRefPubMed Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK (1982) Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 307(8):463–468CrossRefPubMed
27.
go back to reference Stark RP, Maki DG (1984) Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 311(9):560–564CrossRefPubMed Stark RP, Maki DG (1984) Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med 311(9):560–564CrossRefPubMed
28.
go back to reference Walsh CA, Siddins A, Parkin K, Mukerjee C, Moore KH (2011) Prevalence of “low-count” bacteriuria in female urinary incontinence versus continent female controls: a cross-sectional study. Int Urogynecol J 22(10):1267–1272CrossRefPubMed Walsh CA, Siddins A, Parkin K, Mukerjee C, Moore KH (2011) Prevalence of “low-count” bacteriuria in female urinary incontinence versus continent female controls: a cross-sectional study. Int Urogynecol J 22(10):1267–1272CrossRefPubMed
Metadata
Title
Incontinence medication response relates to the female urinary microbiota
Authors
Krystal J. Thomas-White
Evann E. Hilt
Cynthia Fok
Meghan M. Pearce
Elizabeth R. Mueller
Stephanie Kliethermes
Kristin Jacobs
Michael J. Zilliox
Cynthia Brincat
Travis K. Price
Gina Kuffel
Paul Schreckenberger
Xiaowu Gai
Linda Brubaker
Alan J. Wolfe
Publication date
01-05-2016
Publisher
Springer London
Published in
International Urogynecology Journal / Issue 5/2016
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-015-2847-x

Other articles of this Issue 5/2016

International Urogynecology Journal 5/2016 Go to the issue